Dr. Gail S. Kerr, MD

Dr. Kerr practices at Howard University Hospital in Washington, District of Columbia, part of Howard University.

Dr. Kerr's NPI, 1194725184, was assigned on July 31, 2005. Dr. Kerr holds District of Columbia license MD21125.

Dr. Kerr's primary practice is Howard University Hospital, at 2041 Georgia Ave NW, Washington, DC 20060 in The District County. The practice phone is (202) 745-6100.

Dr. Kerr's primary practice is Howard University Hospital in Washington, District of Columbia, part of Howard University. The medical group on file is Howard University Faculty Practice Plan.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kerr practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Kerr's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dmand AI has Dr. Kerr's licenses on file in 2 states: District of Columbia and Maryland.

CMS data shows 40 Medicare services from Dr. Kerr across 3 procedure codes in 2024, for 23 Medicare patients. Medicare paid $3,480 for them. Every service was in an office.

CMS counts 23 Medicare patients who saw Dr. Kerr in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.80, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kerr's median patient age at 58, with 67% women.

In 2024, Dr. Kerr wrote 456 Medicare Part D claims for 39 patients. 68% of them were for generic drugs. CMS names the drug for 357 of them, across 13 drugs with 11 or more claims each, at $597,127 in total drug cost. In 2023, CMS named 158 claims across 6 drugs.

Dr. Kerr accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kerr as offering telehealth.

Dmand AI links 71 papers to Dr. Kerr, published from 2010 to 2025. 2015 was the busiest year, with 6. The most frequent topics are Arthritis, Rheumatoid, Antirheumatic Agents and Veterans. Dr. Kerr has published most often in Arthritis Care Res (Hoboken). Dr. Kerr's most frequent co-authors are Grant Wilson Cannon, MD, Andreas M. Reimold, MD and Ted R. Mikuls, MD.

CMS Open Payments shows 443 general payments to Dr. Kerr from 32 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 71% of the total. UCB, Inc. paid the most, $40,896. It also lists 1 research payment totaling $1,650 in 2025.